Form4insider filings, from the source

Company · CIK 0001501796 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Aura Biosciences, Inc. · AURA

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 AForm 4 →Sep 1, 5:28 pm EDTJulie PersonChief People Officer107,611——107,611—
Sep 1, 2026 AForm 4 →Sep 1, 5:26 pm EDTErica KratzChief Reg. & Quality Officer100,885——100,885—
Sep 1, 2026 AForm 4 →Sep 1, 5:24 pm EDTJanet Jill HopkinsChief Medical Officer58,850——380,190—
Sep 1, 2026 AForm 4 →Sep 1, 5:23 pm EDTAmy ElazzouziSVP, Finance & PAO23,540——143,600—
Sep 1, 2026 AForm 4 →Sep 1, 5:21 pm EDTSusan Abu-AbsiChief Operating Officer134,513——134,513—
Jul 7, 2026 AForm 4 →Jul 8, 4:11 pm EDTJeremy BenderDirector30,000——30,000—
Jul 1, 2026 AForm 4 →Jul 1, 4:35 pm EDTConor KilroySee Remarks14,858——232,693—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 AForm 4 →Sep 1, 5:28 pm EDTJulie PersonChief People Officer212,389——212,389—
Sep 1, 2026 AForm 4 →Sep 1, 5:26 pm EDTErica KratzChief Reg. & Quality Officer199,115——199,115—
Sep 1, 2026 AForm 4 →Sep 1, 5:24 pm EDTJanet Jill HopkinsChief Medical Officer116,150——116,150—
Sep 1, 2026 AForm 4 →Sep 1, 5:23 pm EDTAmy ElazzouziSVP, Finance & PAO46,460——46,460—
Sep 1, 2026 AForm 4 →Sep 1, 5:21 pm EDTSusan Abu-AbsiChief Operating Officer265,487——265,487—
Jul 7, 2026 AForm 4 →Jul 8, 4:11 pm EDTJeremy BenderDirector60,000——60,000—